Update from the 2013 International Neurofibromatosis Conference.
about
Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2.Creation of an international registry to support discovery in schwannomatosis.Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2.[Eye involvement in neurofibromatosis].Neurofibromatosis Type 2.
P2860
Update from the 2013 International Neurofibromatosis Conference.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Update from the 2013 International Neurofibromatosis Conference.
@en
Update from the 2013 International Neurofibromatosis Conference.
@nl
type
label
Update from the 2013 International Neurofibromatosis Conference.
@en
Update from the 2013 International Neurofibromatosis Conference.
@nl
prefLabel
Update from the 2013 International Neurofibromatosis Conference.
@en
Update from the 2013 International Neurofibromatosis Conference.
@nl
P2093
P2860
P50
P356
P1476
Update from the 2013 International Neurofibromatosis Conference.
@en
P2093
Aaron Schindeler
Alison C Lloyd
Anat O Stemmer-Rachamimov
Andrea I McClatchey
Anne C Albers
Brian Weiss
Brigitte C Widemann
Courtney M Dunn
David A Stevenson
David B Parkinson
P2860
P304
P356
10.1002/AJMG.A.36754
P407
P577
2014-09-24T00:00:00Z